A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
Year: 2004
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Authors: F Saint-Martin, J P Dumur, I Pérez, I Izquierdo
Institution: Uriach (Spain)
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2185530710